Palatin Technologies PTN
NASDAQ PTN
$9.69 -0.76 (-7.23%)
At close: Aug 21, 2026 · 4:00 PM EDT

Palatin Technologies (PTN) Profit After Tax (2010 - 2026)

Palatin Technologies' (PTN) quarterly Profit After Tax came in at -$1.4 million in Q1 2026, up 70.22% YoY from -$841859.1 in Q1 2025, and up 80.27% on a QoQ basis from -$7.3 million in Q4 2025.

Palatin Technologies (PTN) Profit After Tax (2010 - 2026) Analysis & Trends

Palatin Technologies (PTN) has 17 years of Profit After Tax data on file, last reported at -$1.4 million in Q1 2026.

  • Quarterly Profit After Tax rose 70.22% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.2 million (up 73.21% YoY) and the FY2025 annual result came in at -$17.3 million, up 41.8% from the prior year.
  • Profit After Tax improved to -$1.4 million in Q1 2026, from -$7.3 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $4.7 million in Q3 2025 to a low of -$12.8 million in Q2 2022.
  • A 5-year average of -$5.6 million and a median of -$7.6 million in 2022 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2023 — Profit After Tax sank 389.72% — and 2025, when it jumped 159.79%.
  • Tracing PTN's Profit After Tax over 5 years: stood at $2.7 million in 2022, then slumped by 389.72% to -$7.8 million in 2023, then jumped by 68.86% to -$2.4 million in 2024, then slumped by 197.4% to -$7.3 million in 2025, then soared by 80.27% to -$1.4 million in 2026.
  • The last three Profit After Tax figures came in at -$1.4 million (Q1 2026), -$7.3 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Palatin Technologies 40.37 Mn 40.37 Mn - -1.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Mn
Dec 31, 2025 -7.26 Mn
Sep 30, 2025 4.68 Mn
Jun 30, 2025 -2.23 Mn
Mar 31, 2025 -4.81 Mn
Dec 31, 2024 -2.44 Mn
Sep 30, 2024 -7.82 Mn
Jun 30, 2024 -8.25 Mn
Mar 31, 2024 -8.44 Mn
Dec 31, 2023 -7.84 Mn
Sep 30, 2023 -5.21 Mn
Jun 30, 2023 -9.82 Mn
Mar 31, 2023 -8.67 Mn
Dec 31, 2022 2.71 Mn
Sep 30, 2022 -8.26 Mn
Jun 30, 2022 -12.77 Mn
Mar 31, 2022 -7.63 Mn
Dec 31, 2021 -8.69 Mn
Sep 30, 2021 -7.11 Mn
Jun 30, 2021 -13.93 Mn